| Jody Herbert, DPT | |
|
931 13th Ave N, Clinton, IA 52732-5072 | |
| (563) 243-7814 | |
| Not Available |
| Full Name | Jody Herbert |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 14 Years |
| Location | 931 13th Ave N, Clinton, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205146438 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PTL-10962 (Colorado) | Secondary |
| 225100000X | Physical Therapist | 1213856 (Texas) | Secondary |
| 225100000X | Physical Therapist | 081462 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rock Valley Physical Therapy Center | 9638087877 | 188 |
News Archive
Luteolin is a flavonoid commonly found in fruit and vegetables. This compound has been shown in laboratory conditions to have anti-inflammatory, anti-oxidant and anti-cancer properties but results from epidemiological studies have been less certain. New research published in BioMed Central's open access journal BMC Gastroenterology shows that luteolin is able to inhibit the activity of cell signaling pathways (IGF and PI3K) important for the growth of cancer in colon cancer cells.
Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today the expansion of its capabilities for cardiac safety and cardiovascular efficacy studies in the company's early phase diabetes and obesity clinical trials.
Despite a national opioid-related overdose epidemic that continues to claim tens of thousands of lives annually, a new nationwide study shows that a scant proportion of hospitalized patients with opioid use disorder receive proven life-saving medications both during and after they're discharged.
An early Positron Emission Tomography (PET) response after the initial cycle of neoadjuvant chemotherapy can be used to predict increased survival in patients with soft tissue sarcomas, according to a study by researchers with UCLA's Jonsson Comprehensive Cancer Center.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Integrated Sciences Pty. Ltd. today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in Australia.
› Verified 9 days ago
| Provider Name | Rock Valley Physical Therapy Center |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1245373166 PECOS PAC ID: 9638087877 Enrollment ID: O20080513000596 |
News Archive
Luteolin is a flavonoid commonly found in fruit and vegetables. This compound has been shown in laboratory conditions to have anti-inflammatory, anti-oxidant and anti-cancer properties but results from epidemiological studies have been less certain. New research published in BioMed Central's open access journal BMC Gastroenterology shows that luteolin is able to inhibit the activity of cell signaling pathways (IGF and PI3K) important for the growth of cancer in colon cancer cells.
Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today the expansion of its capabilities for cardiac safety and cardiovascular efficacy studies in the company's early phase diabetes and obesity clinical trials.
Despite a national opioid-related overdose epidemic that continues to claim tens of thousands of lives annually, a new nationwide study shows that a scant proportion of hospitalized patients with opioid use disorder receive proven life-saving medications both during and after they're discharged.
An early Positron Emission Tomography (PET) response after the initial cycle of neoadjuvant chemotherapy can be used to predict increased survival in patients with soft tissue sarcomas, according to a study by researchers with UCLA's Jonsson Comprehensive Cancer Center.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Integrated Sciences Pty. Ltd. today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in Australia.
› Verified 9 days ago
| Provider Name | Athletico Ltd |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1821085028 PECOS PAC ID: 4789602681 Enrollment ID: O20150820012358 |
News Archive
Luteolin is a flavonoid commonly found in fruit and vegetables. This compound has been shown in laboratory conditions to have anti-inflammatory, anti-oxidant and anti-cancer properties but results from epidemiological studies have been less certain. New research published in BioMed Central's open access journal BMC Gastroenterology shows that luteolin is able to inhibit the activity of cell signaling pathways (IGF and PI3K) important for the growth of cancer in colon cancer cells.
Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today the expansion of its capabilities for cardiac safety and cardiovascular efficacy studies in the company's early phase diabetes and obesity clinical trials.
Despite a national opioid-related overdose epidemic that continues to claim tens of thousands of lives annually, a new nationwide study shows that a scant proportion of hospitalized patients with opioid use disorder receive proven life-saving medications both during and after they're discharged.
An early Positron Emission Tomography (PET) response after the initial cycle of neoadjuvant chemotherapy can be used to predict increased survival in patients with soft tissue sarcomas, according to a study by researchers with UCLA's Jonsson Comprehensive Cancer Center.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Integrated Sciences Pty. Ltd. today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in Australia.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jody Herbert, DPT 5222 Belmont Ave, #239, Dallas, TX 75206-6900 Ph: (309) 737-6780 | Jody Herbert, DPT 931 13th Ave N, Clinton, IA 52732-5072 Ph: (563) 243-7814 |
News Archive
Luteolin is a flavonoid commonly found in fruit and vegetables. This compound has been shown in laboratory conditions to have anti-inflammatory, anti-oxidant and anti-cancer properties but results from epidemiological studies have been less certain. New research published in BioMed Central's open access journal BMC Gastroenterology shows that luteolin is able to inhibit the activity of cell signaling pathways (IGF and PI3K) important for the growth of cancer in colon cancer cells.
Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today the expansion of its capabilities for cardiac safety and cardiovascular efficacy studies in the company's early phase diabetes and obesity clinical trials.
Despite a national opioid-related overdose epidemic that continues to claim tens of thousands of lives annually, a new nationwide study shows that a scant proportion of hospitalized patients with opioid use disorder receive proven life-saving medications both during and after they're discharged.
An early Positron Emission Tomography (PET) response after the initial cycle of neoadjuvant chemotherapy can be used to predict increased survival in patients with soft tissue sarcomas, according to a study by researchers with UCLA's Jonsson Comprehensive Cancer Center.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Integrated Sciences Pty. Ltd. today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in Australia.
› Verified 9 days ago
Amber Voss, Physical Therapist Medicare: Medicare Enrolled Practice Location: 931 13th Ave N, Clinton, IA 52732 Phone: 563-243-7814 Fax: 563-243-2441 | |
Bradley C Hirl, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2900 S 25th St Ste B2, Clinton, IA 52732 Phone: 563-278-8830 Fax: 563-278-8831 | |
Brittney Davis, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 931 13th Ave N, Clinton, IA 52732 Phone: 563-243-7814 Fax: 563-243-2441 | |
Kiri Ann Barker, DPT, ATC/L Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1647 Lincoln Way, Clinton, IA 52732 Phone: 563-242-2900 Fax: 563-242-2903 | |
Kristen Marie Stevenson, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1377 11th St Nw, Clinton, IA 52732 Phone: 563-241-4230 Fax: 563-519-4235 | |
Evan David Hammons, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1377 11th St Nw, Clinton, IA 52732 Phone: 563-241-4230 | |
Olivia Mueller, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 931 13th Ave N, Clinton, IA 52732 Phone: 563-243-7814 |